Haemophilia : the official journal of the World Federation of Hemophilia
Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta-Analysis.
Konstantina Bolou, George Triantafyllou, Athina Dettoraki, Aikaterini Michalopoulou, Miltiades Kyprianou, Olympia Papakonstantinou, Helen Pergantou
Published: 202510.1111/hae.70189
Abstract
INTRODUCTION: Haemophilia A in paediatric patients presents a lifelong risk of spontaneous and trauma-induced haemorrhage, leading to progressive joint damage, disability and impaired quality of life. Emicizumab, a bispecific monoclonal antibody admi…
Preview only. Read the full abstract at the source